Moderna says data show its combination Covid-flu vaccine generates a strong immune response

Taking stock of the drug industry, from the lab to the medicine chest

June 10, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Alex Hogan/STAT STAT+ | Moderna says data show its combination Covid-flu vaccine generates a strong immune response The findings suggest Moderna may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025. By Helen Branswell Opinion: Curing rare childhood diseases will falter unless Congress steps up Without immediate action by lawmakers, the priority review voucher program will expire. That would be a tragedy for countless children. By Joe and Courtney Dion STAT+ | The inside story of how Lykos' MDMA research went awry The psychedelics company oversaw a pattern of lapses during its clinical trials, according to former employees who spoke with STAT. By Olivia Goldhill Tim Boyle/Getty Images Millions fewer people may need statins, a new study suggests. But guidelines have yet to agree The American Heart Association revised its risk model for cardiovascular disease, but the guidelines for statin use haven't caught up. By Elizabeth Cooney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser